Uremic pruritus: A review

Hemodialysis International

Volumn 9, Issue 2, 2005, Pages 180-188

  Lugon, Jocemir Ronaldo ^a,b  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b NONE   (Brazil)

Author keywords

End stage renal disease; Hemodialysis; Itch; Uremia

Indexed keywords

ACTIVATED CARBON; ALBUMIN; ANTIHISTAMINIC AGENT; CAPSAICIN; COLESTYRAMINE; EMOLLIENT AGENT; ENDORPHIN; ERYTHROPOIETIN; FERRITIN; HEPARIN; KETOTIFEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIDOCAINE; NALTREXONE; NICERGOLINE; OMEGA 6 FATTY ACID; ONDANSETRON; OPIATE ANTAGONIST; OPIATE RECEPTOR; PLACEBO; STEROID; TACROLIMUS; TERFENADINE; THALIDOMIDE;

ALBUMIN BLOOD LEVEL; BRAIN CORTEX; CARDIOVASCULAR DISEASE; CELL INTERACTION; CLINICAL TRIAL; DIALYSIS; DISEASE CLASSIFICATION; FERRITIN BLOOD LEVEL; HUMAN; INFLAMMATION; KIDNEY FAILURE; MALNUTRITION; MAST CELL; MORTALITY; NONMYELINATED NERVE; PATHOGENESIS; PREVALENCE; PRURITUS; REVIEW; RISK FACTOR; SENSORY STIMULATION; SIGNAL TRANSDUCTION; UREMIA;

HUMANS; KIDNEY FAILURE, CHRONIC; MAST CELLS; NERVE FIBERS, UNMYELINATED; PRURITUS; RENAL DIALYSIS; UREMIA;

EID: 21744448072     PISSN: 14927535     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1492-7535.2005.01130.x     Document Type: Review

References (83)

1. Matsumoto M, Ichimaru K, Horie A. Pruritus and mast cell proliferation of the skin in end stage renal failure. Clin Nephrol. 1985; 23(6):285-288.
2. Nielsen T, Andersen KE, Kristiansen J. Pruritus and xerosis in patients with chronic renal failure. Dan Med Bull. 1980; 27(6):269-271.
3. Bencini PL, Montagno G, Citterio A, Graziani G, Crosti C, Ponticelli C. Cutaneous abnormalities in uremic patients. Nephron. 1985; 40(3):316-321.
4. Balaskas EV, Chu M, Uldall RP, Gupta A, Oreopoulos DG. Pruritus in continuous ambulatory peritoneal dialysis and hemodialysis patients. Perit Dial Int. 1993; 13(Suppl 2): S527-S532.
5. Pauli-Magnus C, Mikus G, Alscher DM, Kirscher T, Nagel W, Gugeler N, Risler T, Berger ED, Kuhlmann U, Mettang T. Naltrexone does not relive uremic pruritus: Results of a randomized, double-blind, placebo-controlled crossover study. J Am Soc Nephrol. 2000; 11(3):514-519.
6. Andrew D, Craig AD. Spinothalamic lamina I neurons selectively sensitive to histamine: A central neural pathway for itch. Nat Neurosci. 2001; 4(1):72-77.
7. Armstrong CA, Scholzen T, Olerud JE, Bunnett NW, Luger TA, Ansel JC. Neurobiology of the skin. In: Freeberg IM, Eisen AZ, Fitzpatrick TB, eds. Fitzpatrick's dermatology in general medicine. 5th ed, Vol. 1. New York: McGraw-Hill; 1999:321-326.
8. Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebjork HE. Specific C-receptors for itch in human skin. J Neurosci. 1997; 17(20):8003-8008.
9. Hsieh JC, Hagermark O, Stahle-Backdahl M, Ericson K, Eriksson L, Stone-Elander S, Ingvar M. Urge to scratch represented in the human cerebral cortex. J Neurophysiol. 1994; 72(6):3004-3008.
10. Darsow U, Drzezga A, Frisch M, Munz F, Weilke F, Bartenstein P, Schwaiger M, Ring J. Processing of histamine induced itch in the human cerebral cortex: A correlation analysis with dermal reactions. J Invest Dermatol. 2000; 115(6):1029-1033.
11. Drzezga A, Darsow U, Treede RD, Siebner H, Frisch M, Munz F, Weilke F, Ring J, Schwaiger M, Bartenstein P. Central activation by histamine-induced itch: Analogies to pain processing. a correlational analysis of O-15 H2O positron emission tomography studies. Pain. 2001; 92(1-2):295-305.
12. Greaves MW, Wall PD. Pathophysiology of itching. Lancet. 1996; 348(9045):938-940.
13. Herndon JH. Itching: The pathophysiology of pruritus. Int J Dermatol. 1975; 14(7):465-484.
14. Chaney MA. Side effects of intrathecal and epidural opioids. Can J Anaesth. 1995; 42(10):891-903.
15. Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet. 2003; 361(9358):690-694.
16. Kitaura J, Asai K, Maeda-Yamamoto M, Kawakami Y, Kikkawa U, Kawakami T. Akt-dependent cytokine production in mast cells. J Exp Med. 2000; 192(5): 729-739.
17. Davies MG, Greaves MW. Sensory responses of human skin to synthetic histamine analogues and histamine. Br J Pharmacol. 1980; 9(5):461-465.
18. Charlesworth EN, Beltrani VS. Pruritic dermatoses: Overview of etiology and therapy. Am J Med. 2002; 113(Suppl 9A):25S-33S.
19. Steinhoff M, Vergnolle N, Young SH, Tognetto M, Amadesi S, Ennes HS, Trevisani M, Hollenberg MD, Wallace JL, Caughey GH, Mitchell SE, Williams LM, Geppetti P, Mayer EA, Bunnett NW. Agonists of preoteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med. 2000; 6(2):151-158.
20. Hori T, Oka T, Hosoi M, Aou S. Pain modulatory actions of cytokines and prostaglandin E2 in the brain. Ann N Y Acad Sci. 1998; 840:269-281.
21. Darsow U, Scharein E, Bromm B, Ring J. Skin testing of the pruritogenic activity of histamine and cytokines (IL-2 and TNF-α) at the dermal-epidermal junction. Br J Dermatol. 1997; 137(3):415-417.
22. Fjellner B, Hagermark O. Pruritus in polycitemia vera: Treatment with aspirin and possibility of platelet involvement. Acta Derm Venereol. 1979; 59(6):502-512.
23. Hagermark O, Strandberg K, Hamberg M. Potentiation of itch and flare responses in human skin by prostaglandins E2 and H2 and a prostaglandin endoperoxide analog. J Invest Dermatol. 1977; 69(6):527-530.
24. Gilchrest BA, Stern RS, Steinman TI, Brown RS, Arndt KA, Anderson WW. Clinical features of pruritus in patients undergoing maintenance hemodialysis. Arch Dermatol. 1982; 118(3):154-156.
25. Stahle-Backdahl M, Hagermark O, Lins LE. Pruritus in patients on maintenance dialysis. Acta Med Scand. 1988; 224(1):55-56.
26. Young AW Jr, Sweeney EW, David DS, Cheigh J, Hochgelerent EL, Sakai S, Sakai S, Stenzel KH, Rubin AL. Dermatologic evaluation of pruritus in patients on hemodialysis. N Y State J Med. 1973; 73(22):2670-2674.
27. Mettang T, Fritz P, Weber J, Machleidt C, Hubel E, Kuhlmann U. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD): The role of plasma histamine and skin mast cells. Clin Nephrol. 1990; 34(3):136-141.
28. Johansson O, Hilliges M, Stahle-Backdahl M. Intraepidermal neuron-specific enolase (NSE)-immuno-reactive nerve fibres: Evidence for sprouting in uremic patients on maintenance hemodialysis. Neurosci Lett. 1989; 99(3):281-286.
29. Fantini F, Baraldi A, Pincelli A. Neuron-specific enolase-immunoreactive fibres in uremic patients. Acta Derm Venereol. 1990; 70(4):363-365.
30. Klein LR, Klein JB, Hanno R, Callen JP. Cutaneous mast cell quantity in pruritic and nonpruritic hemodialysis patients. Int J Dermatol. 1988; 27(8):557-559.
31. Schwartz IF, Iaina A. Uraemic pruritus. Nephrol Dial Transplant. 1999; 14(4):834-839.
32. Ponticelli C, Bencini PL. Uremic pruritus: A review. Nephron. 1992; 60(1):1-5.
33. Stenvinkel P, Pecoits-Filho R, Lindholm B. Coronary artery disease in end-stage renal disease: No longer a simple plumbing problem. J Am Soc Nephrol. 2003; 14(7):1927-1939.
34. Stam F, van Guldener C, Schalkwijk CG, ter Wee PM, Donker AJ, Stehouwer CD. Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. Nephrol Dial Transplant. 2003; 18(5):892-898.
35. Virga G, Visentin I, La Milia V, Bonadonna A. Inflammation and pruritus in haemodialysis patients. Nephrol Dial Transplant. 2002; 17(12):2164-2169.
36. Balaskas EV, Grapsa E. Uremic pruritus is a poor prognostic factor of outcome. Perit Dial Int. 1995; 15(2): 177.
37. Masi CM, Cohen EP. Dialysis efficacy and itching in renal failure. Nephron. 1992; 62(3):257-261.
38. Saatçi U, Basin E, Ozdemir F, Turan M, Micozkadioglu H, Haberal M. Pruritus and HLA in hemodialysis patients [abstract]. Tissue Antigens. 2002; 60:559.
39. Tarng DC, Cho YL, Liu NH, Huang TP. Hemodialysis-related pruritus: A double-blind placebo-controlled, crossover study of capsaicin 0.025% cream. Nephron. 1996; 72(4):617-622.
40. Gilchrest BA, Rowe JW, Brown RS, Steinman TI, Arndt KA. Ultraviolet phototherapy of uremic pruritus: Long-term results and possible mechanisms of action. Ann Intern Med. 1979; 91(1):17-21.
41. Pederson JA, Matter BJ, Czerwinski AW, Llach F. Relief of idiopathic generalized pruritus in dialysis patient treated with activated oral charcoal. Ann Intern Med. 1980; 93(3):446-448.
42. Silverberg DS, Iaina A, Reisin E, Rotzak R, Eliahou HE. Cholestyramine in uremic pruritus. Br Med J. 1977; 1 (6063):752-753.
43. Bousquet J, Rivory JP, Maheut M, Michel FB, Mion C. Double-blind, placebo-controlled study of nicergoline in the treatment of pruritus in patients receiving maintenance hemodialysis. J Allergy Clin Immunol. 1989; 83(4):825-828.
44. Peer G, Kivity S, Agami O, Fireman E, Silverberg D, Blum M, Iaina A. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet. 1996; 348(9041):1552-1554.
45. Hiroshige K, Kabashima N, Takasugi M, Kuroiwa A. Optimal dialysis improves uremic pruritus. Am J Kidney Dis. 1995; 25(3):413-419.
46. Graf H, Kovarik J, Stummvoll HK, Wolf A. Disappearance of uraemic pruritus after lowering dialysate magnesium concentration. Br Med J. 1979; 2(6203):1478-1479.
47. Carmichael AJ, Dickinson F, McHugh MI, Martin AM, Farrow M. Magnesium free dialysis for uraemic pruritus. Br Med J. 1988; 297(6663):1584-1585.
48. Kyriazis J, Glotsos J. Dialysate calcium concentration of ≤1.25 mmol/l: Is it effective in suppressing uremic pruritus? Nephron. 2000; 84(1):85-86.
49. Morton CA, Lafferty M, Hau C, Henderson I, Jones M, Lowe JG. Pruritus and skin hydration during dialysis. Nephrol Dial Transplant. 1996; 11(10):2031-2036.
50. Cho YL, Liu HN, Huang TP, Tarng DC. Uremic pruritus. Roles of parathyroid hormone and substance P. J Am Acad Dermatol. 1997; 36(4):538-543.
51. Breneman DL, Cardone JS, Blumsack RF. Capsaicin for hemodialysis-related pruritus. J Am Dermatol. 1992; 26(1):91-94.
52. Lugon NV. Cutaneous manifestations in end stage renal disease: Comparison between hemodialysis and transplant patients. Dissertation. Dermatology, Universidade Federal Fluminense.
53. Robertson KE, Mueller BA. Uremic pruritus. Am J Health Syst Pharm. 1996; 53(18):2159-2170.
54. Pauli-Magnus C, Klumpp S, Alscher DM, Kuhlmann U, Mettang T. Short-term efficacy of tacrolimus ointment in severe uremic pruritus. Perit Dial Int. 2000; 20(6): 802-803.
55. Saltzer EI. Relief from uremic pruritis: A therapeutic approach. Cutis. 1975; 16:298-299.
56. Spiro JG, Scott S, MacMillan J, Diffey BL, Hindson TC, Taylor R, Taylor AE, Downey A. Treatment of uremic pruritus with blue light. Photodermatology. 1985; 2(5): 319-321.
57. Blachley JD, Blankenship DM, Menter A, Parker TF 3rd, Knochel JP. Uremic pruritus: Skin divalent ion content and response to ultraviolet phototherapy. Am J Kidney Dis. 1985; 5(5):237-241.
58. Snyder D, Merrill JP. Sauna baths in the treatment of chronic renal failure. Trans Am Soc Artif Intern Organs. 1966; 12:188.
59. Duo LJ. Electrical needle therapy of uremic pruritus. Nephron. 1987; 47(3):179-183.
60. Shapiro R, Stockard H, Schank A. Uremic pruritus successfully controlled with acupuncture. Dial Transplant. 1988; 17:180-183.
61. Shapiro R, Stockard H. Successful treatment of uremic pruritus: The acupuncture approach revisited. Dial Transplant. 2003; 32:257-265.
62. Cavalcanti AM, Rocha LM, Carillo, R Jr, Lima, LO, Lugon JR. Effects of homeopathic treatment on pruritus of haemodialysis patients: A randomized placebo-controlled double-blind trial. Homeopathy. 2003; 92(4):177-181.
63. Hampers CL, Katz AI, Wilson RE, Merrill JP. Disappearance of "uremic" itching after subtotal parathyroidectomy. N Engl J Med. 1968; 279(13):695-697.
64. Massry SG, Popovtzer MM, Coburn JW, Makoff DL, Maxwell MH, Kleeman CR. Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia: Disappearance of itching after subtotal parathyroidectomy. N Engl J Med. 1968; 279(13): 697-700.
65. Altmeyer P, Kachel HG, Schafer G, Fassbinder W. [Normalization of skin changes following kidney transplantation]. Hautarzt. 1986; 37(4):217-221.
66. Russo GE, Spaziani M, Guidotti C, Scarpellini MG, Leri O, Bonini S, Crisciotti C, Carmenini G. [Pruritus in chronic uremic patients in periodic hemodialysis: Treatment with terfenadine (an antagonist of histamine HI receptors)]. Minerva Urol Nefrol. 1986; 18(4):443-447.
67. Bernstein JE, Swift R. Relief of intractable pruritus with naloxone. Arch Dermatol. 1979; 115(11):1366-1367.
68. Andersen LW, Friedberg M, Lokkegaard N. Naloxone in treatment of uremic pruritus: A case history. Clin Nephrol. 1984; 21(6):355-356.
69. Kanai H, Nagashima A, Hirakata E, Hirakata H, Okuda S, Fujimi S, Fujishima M., The effect of azelastin hydrochloride on pruritus and leukotriene B4 in hemodialysis patients. Life Sci. 1995; 57(3):207-213.
70. De Marchi S, Cecchin E, Villalta. D, Sepiacci G, Santini G, Bartoli R. Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia. N Engl J Med. 1992; 126(15):969-974.
71. Yatzidis H, Digenis P, Tountas C. Heparin treatment of uremic itching. J Am Med Assoc. 1972; 222(9):1183.
72. Tapia L, Cheigh JS, David SD, Sullivan JF, Saal S, Reidenberg MM, Stenzel KH, Rubin AL. Pruritus in dialysis patients treated with parenteral lidocaine. N Engl J Med. 1977; 296(5):261-263.
73. Silva SR, Viana PC, Lugon NV, Hoette M, Ruzany F, Lugon JR. Thalidomide for the treatment of uremic pruritus: A crossover randomized double-blind trial. Nephron. 1994; 67(3):270-273.
74. Peck LW, Monsen ER, Ahmad S. Effect of three sources of long-chain fatty acids on the plasma fatty acid profile, plasma prostaglandin E2 concentrations, and pruritus symptoms in hemodialysis patients. Am J Clin Nutr. 1996; 64(2):210-214.
75. Yoshimoto-Furuie K, Yoshimoto K, Tanaka T, Saima S, Kikuchi Y, Shay J, Horrobin DF, Echizen H. Effects of oral supplementation with evening primrose oil for six weeks on plasma essential fatty acids and uremic skin symptoms in hemodialysis patients. Nephron. 1999; 81(2):151-159.
76. Francos GC, Kauh YC, Gittlen SD, Schulman ES, Besarab A, Goyal S, Burke JF Jr. Elevated plasma histamine in chronic uremia: Effects of ketotifen on pruritus. Int J Dermatol. 1991; 30(12):884-889.
77. Balaskas EV, Uldall RP. Erythropoietin does not improve uremic pruritus [letter]. Peritoneal Dial Int. 1992; 12:330.
78. Balaskas EV, Bamihas GI, Karamouzis M, Voyiatzis G, Tourkantonis A. Histamine and serotonin in uremic pruritus: Effect of ondansetron in CAPD-pruritic patients. Nephron. 1998; 78(4):395-402.
79. Ashmore SD, Jones CH, Newstead CG, Daly MJ, Chrystyn H. Ondansetron therapy for uremic pruritus in hemodialysis patients. Am J Kidney Dis. 2000; 35(5):827-831.
80. Meierhofer C, Wiedermann CJ. New insights into the pharmacological and toxicological effects of thalidomide. Curr Opin Drug Discov Devel. 2003; 6(1):92-99.
81. Chaudhry V, Corrnblath DR, Corse A, Freimer M, Simmons-O'Brien E, Vogelsang G. Thalidomide-induced neuropathy. Neurology. 2002; 59(12):1872-1875.
82. Friga V, Linos A, Linos DA. Is aluminum toxicity responsible for uremic pruritus in chronic hemodialysis patients? Nephron. 1997; 75(1):48-53.
83. Massey WA, Charlesworth EN, Freidhoff L, Cooper P, Kagey-Sobotka A, Lichtenstein LM. Cutaneous IgE-mediated inflammatory lesion size is inhibited by an H1 antagonist (terfenadine) while mediator release is unaffected in vivo and in vitro. Clin Exp Allergy. 1993; 23(5):399-405.